Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
NV354
Tag: NV354
Raising awareness around patients with mitochondrial diseases
19 September, 2022
A new approach to mitochondrial diseases
10 August, 2022
Abliva secures funding to advance KL1333 into phase II/III
3 June, 2022
Abliva on the 200 MSEK financing round
1 June, 2022
Celebrating IND approval Abliva eyes next step with KL1333
7 March, 2022
Abliva is ready for a pivotal year
3 February, 2022
Abliva on the IND-approval from FDA
15 December, 2021
FDA approves Abliva’s IND-application for KL1333
26 November, 2021
Abliva’s NV354 targets fatal paediatric disease
27 October, 2021
Raising awareness of mitochondrial diseases
23 September, 2021
1
2
Page 1 of 2